IP Library Granted Patent US 10,787,701
Granted Patent B2
US 10,787,701 · App. 16/414,213 · Granted Sep 29, 2020

Spatially encoded biological assays

Inventor: Mark S. Chee (San Diego, CA)
Assignee: Prognosys Biosciences, Inc.
C12Q1/6837C12Q1/68C12Q1/6804C12Q1/6809C12Q1/6834C12Q1/6841C12Q1/6869C12Q1/6874C40B30/04C40B60/04G01N33/5308G01N33/54366G01N33/6845G01N2458/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,787,701
App. No.
16/414,213
Granted
Sep 29, 2020
Kind
B2
Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

Claims (33)

1. A method of determining presence or abundance or both of a target biological molecule at a region of interest in a tissue sample, comprising:

(a) delivering a plurality of probes to a tissue sample, wherein a probe of the plurality of probes comprises a capture agent that specifically binds a target biological molecule of the tissue sample, wherein the capture agent is conjugated to an oligonucleotide having a sequence;

(b) separating the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at a region of interest in the tissue sample from a plurality of probes not specifically bound to the target biological molecule at the region of interest in the tissue sample;

(c) determining all or a portion of the sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample via hybridization of a probe comprising (i) a sequence that is 100% complementary to a portion of the sequence of the oligonucleotide and (ii) a label; and

(d) using the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample to determine presence or abundance or both of the target biological molecule at the region of interest in the tissue sample.

2. The method of claim 1 , wherein the method further comprises obtaining an image of the tissue sample.

3. The method of claim 1 , wherein step (b) comprises washing the tissue sample to separate the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample from the plurality of probes not specifically bound to the target biological molecule at the region of interest in the tissue sample.

4. The method of claim 1 , wherein step (c) comprises detecting the label.

5. The method of claim 1 , wherein the label is a fluorophore.

6. The method of claim 5 , wherein step (c) comprises detecting the fluorophore.

7. The method of claim 1 , wherein the target biological molecule comprises a nucleic acid.

8. The method of claim 7 , wherein the nucleic acid is DNA.

9. The method of claim 8 , wherein the DNA is genomic DNA.

10. The method of claim 7 , wherein the nucleic acid is mRNA.

11. The method of claim 7 , wherein the nucleic acid comprises a single nucleotide polymorphism or a mutation.

12. The method of claim 1 , wherein the target biological molecule comprises a protein.

13. The method of claim 12 , wherein the capture agent is a small molecule or a substrate for an enzyme.

14. The method of claim 12 , wherein the capture agent is an antibody.

15. The method of claim 1 , wherein the target biological molecule is present in a subcellular target.

16. The method of claim 15 , wherein the subcellular target comprises a mitochondrion or a nucleus.

17. The method of claim 1 , wherein the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample is used to determine the presence of the target biological molecule at the region of interest in the tissue sample.

18. The method of claim 1 , wherein the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample is used to determine the abundance of the target biological molecule at the region of interest in the tissue sample.

19. The method of claim 1 , wherein the determined sequence of the oligonucleotide of the probe of the plurality of probes comprising the capture agent that is specifically bound to the target biological molecule at the region of interest in the tissue sample is used to determine associate the presence and abundance of the target biological molecule at the region of interest in the tissue sample.

20. The method of claim 1 , wherein two or more probes of the plurality of probes specifically bind to unique target biological molecules of the tissue sample.

21. The method of claim 20 , wherein step (c) comprises determining all or a portion of the sequence of the oligonucleotide of the two or more probes in parallel.

22. The method of claim 20 , wherein the two or more probes is at least one thousand probes.

23. The method of claim 1 , wherein the plurality of probes is delivered to multiple regions of interest in the tissue sample.

24. The method of claim 23 , wherein the method further comprises detecting differential expression of the target biological molecule in two or more of the multiple regions of interest of the tissue sample.

25. The method of claim 23 , wherein two or more of the multiple regions of interest are determined by histological features of the tissue sample.

26. The method of claim 1 , wherein the method further comprises identifying a location of the target biological molecule in two or more serial sections of the tissue sample.

27. The method of claim 26 , wherein the method further comprises generating a 3 -dimensional map of the target biological molecule in the tissue sample.

28. The method of claim 1 , wherein the tissue sample is a tissue section.

29. The method of claim 28 , wherein the tissue section comprises a fresh-frozen or formalin-fixed paraffin embedded (FFPE) tissue sample.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2019
From: CHEE, MARK S.
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 049278/0147 →
Continuity (6)
Continuation 16402098 · May 2, 2019
Continuation 16276235 · Feb 14, 2019
Continuation 15187661 · Jun 20, 2016
Continuation 13080616 · Apr 5, 2011
Provisional Application 61321124 · Apr 5, 2010
Related Publication 20190271031A1 · Sep 5, 2019
Cited By (43)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,399,123 US 12,404,544 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,510,744 US 12,529,094 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,646,340 US 12,655,474 US 12,668,835 US 12,692,492